The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
Fibromyalgia is a condition of chronic widespread pain, sleep disturbance and fatigue. Most
of the patients with fibromyalgia complain of either non-restorative sleep or complaints of
disturbed sleep due to pain. The study aimed at examining the effects of milnacipran on sleep
disturbance in patients with fibromyalgia. The study is a randomized, double-blind, placebo
controlled, two way crossover polysomnography (PSG) study to explore the effects of
milnacipran on sleep disturbance. Patients received either milnacipran 50 mg twice a day
(BID) or matching placebo.